| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |